Cargando…

A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases

Drug-related adverse events or adverse drug reactions (ADRs) are currently partially or substantially under-reported. ADR reporting systems need to expand their focus to include sex- and gender-related factors in order to understand, prevent, or reduce the occurrence of ADRs in all people, particula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brabete, Andreea C., Greaves, Lorraine, Maximos, Mira, Huber, Ella, Li, Alice, Lê, Mê-Linh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950058/ https://www.ncbi.nlm.nih.gov/pubmed/35337096 http://dx.doi.org/10.3390/ph15030298

Ejemplares similares

Sex, Gender, and the Regulation of Prescription Drugs: Omissions and Opportunities
por: Greaves, Lorraine, et al.
Publicado: (2023)

Sex, Gender, and Alcohol Use: Implications for Women and Low-Risk Drinking Guidelines
por: Greaves, Lorraine, et al.
Publicado: (2022)

Sex- and Gender-Based Analysis in Cannabis Treatment Outcomes: A Systematic Review
por: Brabete, Andreea C., et al.
Publicado: (2020)

Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities
por: Desai, Mira
Publicado: (2022)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
por: Jo, Hyeong-Geun, et al.
Publicado: (2021)

Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)

Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases
por: Jong, Miek C., et al.
Publicado: (2021)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Adverse Drug Reactions and Potentially Inappropriate Medication in Older Patients: Analysis of the Portuguese Pharmacovigilance Database
por: Gomes, Daniel, et al.
Publicado: (2022)

Adverse effects of gender‐affirming hormonal therapy in transgender persons: Assessing reports in the French pharmacovigilance database
por: Yelehe, Melissa, et al.
Publicado: (2022)

Missing in Action: Sex and Gender in Substance Use Research
por: Greaves, Lorraine
Publicado: (2020)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
por: Sartori, Daniele, et al.
Publicado: (2020)

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
por: Karapetiantz, Pierre, et al.
Publicado: (2018)

Better science with sex and gender: Facilitating the use of a sex and gender-based analysis in health research
por: Johnson, Joy L, et al.
Publicado: (2009)

Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation
por: Ozcan, Gulnihal, et al.
Publicado: (2016)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
por: Choi, Jung-Yoon, et al.
Publicado: (2021)

Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database
por: Pueyo-Val, Javier, et al.
Publicado: (2023)

How Important is Gender in Leadership in Pharmacovigilance? Personal Reflections from the First Female President of the International Society of Pharmacovigilance
por: Harrison-Woolrych, Mira
Publicado: (2022)

Sex and Gender Interactions on the Use and Impact of Recreational Cannabis
por: Greaves, Lorraine, et al.
Publicado: (2020)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Sex, Gender and Health: Mapping the Landscape of Research and Policy
por: Greaves, Lorraine, et al.
Publicado: (2022)

Gender Norms, Roles and Relations and Cannabis-Use Patterns: A Scoping Review
por: Hemsing, Natalie, et al.
Publicado: (2020)

Why sex and gender matter in implementation research
por: Tannenbaum, Cara, et al.
Publicado: (2016)

Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2021)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries
por: Yadav, Sachdev
Publicado: (2008)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
por: Sahu, Ram Kumar, et al.
Publicado: (2014)

Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting
por: Hadi, Muhammad Abdul, et al.
Publicado: (2017)

Healthcare professionals’ awareness and knowledge of adverse drug reactions and pharmacovigilance
por: Almandil, Noor B.
Publicado: (2016)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023)

An adverse drug reaction clinic: Breathing fresh life into the pharmacovigilance programme
por: Brashier, Dick B. S., et al.
Publicado: (2012)

Under-reporting of adverse drug reactions: A challenge for pharmacovigilance in India
por: Tandon, Vishal R., et al.
Publicado: (2015)

Antiretroviral adverse drug reactions pharmacovigilance in Harare City, Zimbabwe, 2017
por: Mugauri, Hamufare, et al.
Publicado: (2018)

Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal
por: Shrestha, Sunil, et al.
Publicado: (2020)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study
por: Monteiro, Cristina, et al.
Publicado: (2021)

PHARMACOVIGILANCE: SCOPE FOR A DERMATOLOGIST
por: Prakash, Bhanu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4f6rlerrjoj2ki882sain8o87p